Claraphi Advisory Network’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-24,918
| Closed | -$84K | – | 318 |
|
|
2020
Q2 | $84K | Buy |
24,918
+20,914
| +522% | +$70.5K | 0.04% | 268 |
|
|
2020
Q1 | $15K | Sell |
4,004
-7,650
| -66% | -$28.7K | 0.01% | 702 |
|
|
2019
Q4 | $70K | Sell |
11,654
-3,090
| -21% | -$18.6K | 0.04% | 199 |
|
|
2019
Q3 | $111K | Sell |
14,744
-2,759
| -16% | -$20.8K | 0.07% | 240 |
|
|
2019
Q2 | $237K | Buy |
17,503
+5,532
| +46% | +$74.9K | 0.14% | 190 |
|
|
2019
Q1 | $65K | Buy |
+11,971
| New | +$65K | 0.04% | 232 |
|